Hepatitis B Anti-CORE
Brief Description
The LIAISON® XL Anti-HBc assay is an in vitro chemiluminescent immunoassay (CLIA) for the qualitative detection of IgG and IgM (total) antibodies to hepatitis B core antigen (anti-HBc) in human serum on the LIAISON® XL Analyzer. Assay results in conjunction with other laboratory results and clinical information may be used as an aid in the diagnosis of hepatitis B virus (HBV) infection in patients with symptoms of hepatitis or who may be at risk for HBV infection.
Laboratory Unit
Immunology
Methodology
Chemiluminescence Immunoassay (CLIA)
Specimen Collection
Serum:
Collect in gold top SST tube, centrifuge
Collect in tiger top SST tube, centrifuge
Storage/Transport
Serum separated from the clot can be maintained at refrigerated temperature (2-8°C) during transit for no more than four days after collection. Serum separated from the clot can be aliquoted, stored frozen (-20°C or colder) and shipped with dry ice.
Acceptable Specimen Type(s)
Serum
Test Request
- GPHL Apollo Web Portal
-
Web
Portal Instructions
- For manual orders, download the
GPHL
Submission Form
Possible Results
- Reactive
- Nonreactive
- Unsatisfactory
Reference Range
Nonreactive
Unacceptable Conditions
- Missing testing requisition
- Missing minimum of 2 patient identifiers
- Improper labeling
- Improper storage/transport of specimen
- No specimen received (empty collection tube).
- Wrong specimen type
- Specimen damaged, broken, or leaking upon arrival
Interfering Substances
N/A
Result Reported
3-5 business days
5-7 business days – Antigen positives
Fees
LOINC/Order Codes
77190-7 (Order code: 1410)